Albert Rosenberger

Mr. Albert Rosenberger

Universitätsmedizin Göttingen (UMG)
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2011 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
ARAlbert Rosenberger
Albert Rosenberger
HBHeike Bickeböller
Heike Bickeböller
VMValerie McCormack
Valerie McCormack
DBDarren R. Brenner
Darren R. Brenner
EDEric J. Duell
Eric J. Duell
RHRayjean J. Hung
Rayjean J. Hung
Asthma has been hypothesized to be associated with lung cancer (LC) risk. We conducted a pooled analysis of 16 studies in the International Lung Cancer Consortium (ILCCO) to quantitatively assess this association and compared the results with 36 previously published studies. In total, information from 585 444 individuals was used. Study-specific measures were combined using random effects models. A meta-regression and subgroup meta-analyses were performed to identify sources of heterogeneity. The overall LC relative risk (RR) associated with asthma was 1.28 [95% confidence intervals (CIs) = 1.16–1.41] but with large heterogeneity ( I2 = 73%, P < 0.001) between studies. Among ILCCO studies, an increased risk was found for squamous cell (RR = 1.69, 95%, CI = 1.26–2.26) and for small-cell carcinoma (RR = 1.71, 95% CI = 0.99–2.95) but was weaker for adenocarcinoma (RR = 1.09, 95% CI = 0.88–1.36). The increased LC risk was strongest in the 2 years after asthma diagnosis (RR = 2.13, 95% CI = 1.09–4.17) but subjects diagnosed with asthma over 10 years prior had no or little increased LC risk (RR = 1.10, 95% CI = 0.94–1.30). Because the increased incidence of LC was chiefly observed in small cell and squamous cell lung carcinomas, primarily within 2 years of asthma diagnosis and because the association was weak among never smokers, we conclude that the association may not reflect a causal effect of asthma on the risk of LC.

25 February 2008 in BMC Cancer
Verified
Journal Article
Open access
PDF file
ARAlbert Rosenberger
Albert Rosenberger
TIThomas Illig
Thomas Illig
KKKatrin Korb
Katrin Korb
NKNorman Klopp
Norman Klopp
VZVera Zietemann
Vera Zietemann
HWH-Erich Wichmann
H-Erich Wichmann
Early onset lung cancer shows some familial aggregation, pointing to a genetic predisposition. This study was set up to investigate the role of candidate genes in the susceptibility to lung cancer patients younger than 51 years at diagnosis. 246 patients with a primary, histologically or cytologically confirmed neoplasm, recruited from 2000 to 2003 in major lung clinics across Germany, were matched to 223 unrelated healthy controls. 11 single nucleotide polymorphisms of genes with reported associations to lung cancer have been genotyped. Genetic associations or gene-smoking interactions was found for GPX1(Pro200Leu) and EPHX1(His113Tyr). Carriers of the Leu-allele of GPX1(Pro200Leu) showed a significant risk reduction of OR = 0.6 (95% CI: 0.4–0.8, p = 0.002) in general and of OR = 0.3 (95% CI:0.1–0.8, p = 0.012) within heavy smokers. We could also find a risk decreasing genetic effect for His-carriers of EPHX1(His113Tyr) for moderate smokers (OR = 0.2, 95% CI:0.1–0.7, p = 0.012). Considered both variants together, a monotone decrease of the OR was found for smokers (OR of 0.20; 95% CI: 0.07–0.60) for each protective allele. Smoking is the most important risk factor for young lung cancer patients. However, this study provides some support for the T-Allel of GPX1(Pro200Leu) and the C-Allele of EPHX1(His113Tyr) to play a protective role in early onset lung cancer susceptibility.

11 May 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
XJXuemei Ji
Xuemei Ji
SMSemanti Mukherjee
Semanti Mukherjee
MLMaria Teresa Landi
Maria Teresa Landi
YBYohan Bossé
Yohan Bossé
Philippe JoubertPhilippe Joubert
Philippe Joubert
CAChristopher I. Amos
Christopher I. Amos
Few germline mutations are known to affect lung cancer risk. We performed analyses of rare variants from 39,146 individuals of European ancestry and investigated gene expression levels in 7,773 samples. We find a large-effect association with an ATM L2307F (rs56009889) mutation in adenocarcinoma for discovery (adjusted Odds Ratio = 8.82, P = 1.18 × 10−15) and replication (adjusted OR = 2.93, P = 2.22 × 10−3) that is more pronounced in females (adjusted OR = 6.81 and 3.19 and for discovery and replication). We observe an excess loss of heterozygosity in lung tumors among ATM L2307F allele carriers. L2307F is more frequent (4%) among Ashkenazi Jewish populations. We also observe an association in discovery (adjusted OR = 2.61, P = 7.98 × 10−22) and replication datasets (adjusted OR = 1.55, P = 0.06) with a loss-of-function mutation, Q4X (rs150665432) of an uncharacterized gene, KIAA0930. Our findings implicate germline genetic variants in ATM with lung cancer susceptibility and suggest KIAA0930 as a novel candidate gene for lung cancer risk.

1 April 2014 in DNA Repair
Verified
Journal Article
Closed access
SHSabine Hornhardt
Sabine Hornhardt
URUte Rößler
Ute Rößler
WSWiebke Sauter
Wiebke Sauter
ARAlbert Rosenberger
Albert Rosenberger
TIThomas Illig
Thomas Illig
MGMaria Gomolka
Maria Gomolka

3 July 2018 in International Archives of Occupational and Environmental Health
Verified
Journal Article
Closed access
PDF file
ARAlbert Rosenberger
Albert Rosenberger
RHRayjean J. Hung
Rayjean J. Hung
DCDavid C. Christiani
David C. Christiani
NCNeil E. Caporaso
Neil E. Caporaso
GLGeoffrey Liu
Geoffrey Liu
MGMaria Gomolka
Maria Gomolka

8 March 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ARAlbert Rosenberger
Albert Rosenberger
MSMelanie Sohns
Melanie Sohns
SFStefanie Friedrichs
Stefanie Friedrichs
RHRayjean J. Hung
Rayjean J. Hung
GFGord Fehringer
Gord Fehringer
HBHeike Bickeböller
Heike Bickeböller
Gene-set analysis (GSA) is an approach using the results of single-marker genome-wide association studies when investigating pathways as a whole with respect to the genetic basis of a disease. We performed a meta-analysis of seven GSAs for lung cancer, applying the method META-GSA. Overall, the information taken from 11,365 cases and 22,505 controls from within the TRICL/ILCCO consortia was used to investigate a total of 234 pathways from the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. META-GSA reveals the systemic lupus erythematosus KEGG pathway hsa05322, driven by the gene region 6p21-22, as also implicated in lung cancer (p = 0.0306). This gene region is known to be associated with squamous cell lung carcinoma. The most important genes driving the significance of this pathway belong to the genomic areas HIST1-H4L, -1BN, -2BN, -H2AK, -H4K and C2/C4A/C4B. Within these areas, the markers most significantly associated with LC are rs13194781 (located within HIST12BN) and rs1270942 (located between C2 and C4A). We have discovered a pathway currently marked as specific to systemic lupus erythematosus as being significantly implicated in lung cancer. The gene region 6p21-22 in this pathway appears to be more extensively associated with lung cancer than previously assumed. Given wide-stretched linkage disequilibrium to the area APOM/BAG6/MSH5, there is currently simply not enough information or evidence to conclude whether the potential pleiotropy of lung cancer and systemic lupus erythematosus is spurious, biological, or mediated. Further research into this pathway and gene region will be necessary.